These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 21676117

  • 1. Adherence to lipid-lowering agents among 11,042 patients in clinical practice.
    Wong MC, Jiang JY, Griffiths SM.
    Int J Clin Pract; 2011 Jul; 65(7):741-8. PubMed ID: 21676117
    [Abstract] [Full Text] [Related]

  • 2. Subjects at risk of discontinuation of lipid-lowering agents: a 6-month cohort study among 12,875 patients in a chinese population.
    Wong MC, Jiang JY, Yan BP, Griffiths SM.
    Clin Ther; 2011 May; 33(5):617-28. PubMed ID: 21665046
    [Abstract] [Full Text] [Related]

  • 3. Discontinuation of angiotensin-converting enzyme inhibitors: a cohort study.
    Wong MC, Lau RK, Jiang JY, Griffiths SM.
    J Clin Pharm Ther; 2012 Jun; 37(3):335-41. PubMed ID: 22023456
    [Abstract] [Full Text] [Related]

  • 4. Short-term adherence to beta-blocker therapy among ethnic Chinese patients with hypertension: a cohort study.
    Wong MC, Jiang JY, Griffiths SM.
    Clin Ther; 2009 Oct; 31(10):2170-7; discussion 2150-1. PubMed ID: 19922888
    [Abstract] [Full Text] [Related]

  • 5. Factors associated with antihypertensive drug compliance in 83,884 Chinese patients: a cohort study.
    Wong MC, Jiang JY, Griffiths SM.
    J Epidemiol Community Health; 2010 Oct; 64(10):895-901. PubMed ID: 20693495
    [Abstract] [Full Text] [Related]

  • 6. Switching of antihypertensive drugs among 93,286 Chinese patients: a cohort study.
    Wong MC, Jiang JY, Griffiths SM.
    J Hum Hypertens; 2010 Oct; 24(10):669-77. PubMed ID: 20054349
    [Abstract] [Full Text] [Related]

  • 7. [Adherence to antihypertensive and lipid-lowering medications: a problem of public health, not yet resolved].
    Grosso G, Raciti T, Marventano S, Romeo I, Mistretta A.
    Ann Ig; 2011 Oct; 23(2):173-84. PubMed ID: 21770233
    [Abstract] [Full Text] [Related]

  • 8. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.
    Wu J, Seiber E, Lacombe VA, Nahata MC, Balkrishnan R.
    Ann Pharmacother; 2011 Mar; 45(3):342-9. PubMed ID: 21325098
    [Abstract] [Full Text] [Related]

  • 9. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
    Sung SK, Lee SG, Lee KS, Kim DS, Kim KH, Kim KY.
    Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
    [Abstract] [Full Text] [Related]

  • 10. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G, Conti V, Merlino L, Catapano AL, Mancia G.
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [Abstract] [Full Text] [Related]

  • 11. Factors associated with compliance to thiazide diuretics among 8551 Chinese patients.
    Wong MC, Jiang JY, Griffiths SM.
    J Clin Pharm Ther; 2011 Apr; 36(2):179-86. PubMed ID: 21366647
    [Abstract] [Full Text] [Related]

  • 12. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.
    Ye X, Gross CR, Schommer J, Cline R, St Peter WL.
    Clin Ther; 2007 Dec; 29(12):2748-57. PubMed ID: 18201593
    [Abstract] [Full Text] [Related]

  • 13. Transition probabilities and predictors of adherence in a California Medicaid population using antihypertensive and lipid-lowering medications.
    Nichol MB, Knight TK, Wu J, Tang SS, Cherry SB, Benner JS, Hussein M.
    Value Health; 2009 Jun; 12(4):544-50. PubMed ID: 19138308
    [Abstract] [Full Text] [Related]

  • 14. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
    Hussein MA, Chapman RH, Benner JS, Tang SS, Solomon HA, Joyce A, Foody JM.
    Am J Cardiovasc Drugs; 2010 Jun; 10(3):193-202. PubMed ID: 20387911
    [Abstract] [Full Text] [Related]

  • 15. Factors associated with compliance to lipid-lowering treatment in China.
    Xie G, Zaman MJ, Myint PK, Liang L, Zhao L, Wu Y.
    Eur J Prev Cardiol; 2013 Apr; 20(2):229-37. PubMed ID: 22345695
    [Abstract] [Full Text] [Related]

  • 16. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
    Sedjo RL, Cox ER.
    Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498
    [Abstract] [Full Text] [Related]

  • 17. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
    Chodick G, Shalev V, Gerber Y, Heymann AD, Silber H, Simah V, Kokia E.
    Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
    [Abstract] [Full Text] [Related]

  • 18. Duration of initial antihypertensive prescription and medication adherence: a cohort study among 203,259 newly diagnosed hypertensive patients.
    Wong MC, Tam WW, Wang HH, Cheung CS, Tong EL, Cheung NT, Leeder SR, Griffiths SM.
    Int J Cardiol; 2015 Mar 01; 182():503-8. PubMed ID: 25638445
    [Abstract] [Full Text] [Related]

  • 19. Determinants of medication adherence and blood pressure control among hypertensive patients in Hong Kong: a cross-sectional study.
    Kang CD, Tsang PP, Li WT, Wang HH, Liu KQ, Griffiths SM, Wong MC.
    Int J Cardiol; 2015 Mar 01; 182():250-7. PubMed ID: 25585359
    [Abstract] [Full Text] [Related]

  • 20. Gender disparities in lipid-lowering therapy among veterans with diabetes.
    Vimalananda VG, Miller DR, Palnati M, Christiansen CL, Fincke BG.
    Womens Health Issues; 2011 Mar 01; 21(4 Suppl):S176-81. PubMed ID: 21724138
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.